ELI LILLY AND COMPANY Dividends Per Share
ELI LILLY AND COMPANY (LLY) reported Dividends Per Share of $3.46 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:CommonStockDividendsPerShareDeclared · last filed 2026-08-05
- ELI LILLY AND COMPANY common stock, dividends, per share, declared for the quarter ending 2026-06-30 was $3.46, a 15.33% increase year-over-year.
- ELI LILLY AND COMPANY common stock, dividends, per share, declared for the quarter ending 2025-12-31 was $3.23, a 15.36% increase year-over-year.
- ELI LILLY AND COMPANY common stock, dividends, per share, declared for the quarter ending 2025-09-30 was $0.00.
- ELI LILLY AND COMPANY common stock, dividends, per share, declared for the quarter ending 2025-06-30 was $3.00, a 15.38% increase year-over-year.
- ELI LILLY AND COMPANY common stock, dividends, per share, declared for fiscal 2025 was $6.23, a 15.37% increase from fiscal 2024.
- ELI LILLY AND COMPANY common stock, dividends, per share, declared for fiscal 2024 was $5.40, a 15.14% increase from fiscal 2023.
- ELI LILLY AND COMPANY common stock, dividends, per share, declared for fiscal 2023 was $4.69, a 15.23% increase from fiscal 2022.
- ELI LILLY AND COMPANY common stock, dividends, per share, declared for fiscal 2022 was $4.07, a 15.30% increase from fiscal 2021.
| Period end | Common Stock, Dividends, Per Share, Declared 3 month | Common Stock, Dividends, Per Share, Declared 6 month | Common Stock, Dividends, Per Share, Declared 9 month | Common Stock, Dividends, Per Share, Declared 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.46 10-Q · filed 2026-08-05 | $3.46 10-Q · filed 2026-08-05 | ||
| 2025-12-31 | $3.23 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $3.23 derived: sum of 2 quarters · filed 2026-02-12 | $6.23 derived: sum of 3 quarters · filed 2026-08-05 | $6.23 10-K · filed 2026-02-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.00 derived: sum of 2 quarters · filed 2026-08-05 | $3.00 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $3.00 10-Q · filed 2026-08-05 | $3.00 10-Q · filed 2026-08-05 | ||
| 2024-12-31 | $2.80 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $2.80 derived: sum of 2 quarters · filed 2026-02-12 | $5.40 derived: sum of 3 quarters · filed 2026-02-12 | $5.40 10-K · filed 2026-02-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.60 derived: sum of 2 quarters · filed 2025-10-30 | $2.60 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $2.60 10-Q · filed 2025-08-07 | $2.60 10-Q · filed 2025-08-07 | ||
| 2023-12-31 | $2.43 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $2.43 derived: sum of 2 quarters · filed 2026-02-12 | $4.69 derived: sum of 3 quarters · filed 2026-02-12 | $4.69 10-K · filed 2026-02-12 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $2.26 derived: sum of 2 quarters · filed 2024-10-30 | $2.26 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $2.26 10-Q · filed 2024-08-08 | $2.26 10-Q · filed 2024-08-08 | ||
| 2022-12-31 | $2.11 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $2.11 derived: sum of 2 quarters · filed 2025-02-19 | $4.07 derived: sum of 3 quarters · filed 2025-02-19 | $4.07 10-K · filed 2025-02-19 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.96 derived: sum of 2 quarters · filed 2023-11-02 | $1.96 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $1.96 10-Q · filed 2023-08-08 | $1.96 10-Q · filed 2023-08-08 | ||
| 2021-12-31 | $1.83 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $1.83 derived: sum of 2 quarters · filed 2024-02-21 | $3.53 derived: sum of 3 quarters · filed 2024-02-21 | $3.53 10-K · filed 2024-02-21 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $1.70 derived: sum of 2 quarters · filed 2022-11-01 | $1.70 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $1.70 10-Q · filed 2022-08-04 | $1.70 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | $1.59 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $2.33 derived: sum of 2 quarters · filed 2023-02-22 | $3.07 derived: sum of 3 quarters · filed 2023-02-22 | $3.07 10-K · filed 2023-02-22 |
| 2020-09-30 | $0.74 10-Q · filed 2021-10-27 | $1.48 derived: sum of 2 quarters · filed 2021-10-27 | $1.48 10-Q · filed 2021-10-27 | |
| 2020-06-30 | $0.74 10-Q · filed 2021-08-03 | $0.74 10-Q · filed 2021-08-03 | ||
| 2019-12-31 | $1.39 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.39 derived: sum of 2 quarters · filed 2022-02-23 | $2.68 derived: sum of 3 quarters · filed 2022-02-23 | $2.68 10-K · filed 2022-02-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $1.29 derived: sum of 2 quarters · filed 2020-10-28 | $1.29 10-Q · filed 2020-10-28 | |
| 2019-06-30 | $1.29 10-Q · filed 2020-07-31 | $1.29 10-Q · filed 2020-07-31 | ||
| 2018-12-31 | $1.20 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $1.20 derived: sum of 2 quarters · filed 2021-02-17 | $2.33 derived: sum of 3 quarters · filed 2021-02-17 | $2.33 10-K · filed 2021-02-17 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $1.13 derived: sum of 2 quarters · filed 2019-10-25 | $1.13 10-Q · filed 2019-10-25 | |
| 2018-06-30 | $1.13 10-Q · filed 2019-08-02 | $1.13 10-Q · filed 2019-08-02 | ||
| 2017-12-31 | $1.08 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $2.12 10-K · filed 2020-02-19 | ||
| 2017-09-30 | $1.04 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | $2.05 8-K · filed 2019-10-24 | |||
| 2011-12-31 | $1.96 10-K · filed 2012-02-24 | |||
| 2010-12-31 | $1.96 10-K · filed 2012-02-24 | |||
| 2009-12-31 | $1.96 10-K · filed 2012-02-24 | |||
| 2008-12-31 | $1.90 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |